Tech Company Financing Transactions
BioMarker Strategies Funding Round
Private investors participated in a $2.3 million venture round for BioMarker Strategies. The round was announced on 9/28/2011.
Transaction Overview
Company Name
Announced On
9/28/2011
Transaction Type
Venture Equity
Amount
$2,327,500
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing-amended.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
15601 Crabbs Branch Way
Baltimore, MD 20855
USA
Baltimore, MD 20855
USA
Phone
Website
Email Address
Overview
BioMarker Strategies offers SnapPath, a live tumor cell testing platform that improves the treatment of cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Jack Davis
Chief Executive Officer
Jerry Parrott
Chief Medical Officer
Douglas Clark
Chief Technical Officer
Glenn Miller
VP - R & D
Greg Bertenshaw
Browse more venture capital transactions:
Prev: 9/28/2011: Fundly venture capital transaction
Next: 9/28/2011: BetterLesson venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs